17/05/2019 2nd Joint International Scientific Meeting: "Meet the Expert" | G. Dimas | New insights in NAFLD and Diabetic Nephropathy in patients with Diabetes Mellitus type 2

1,492 VIEWS EXPANDCOLLAPSE Αρχείο

Share

50,064 total
306 live
1,492 video
19,011 photo
Views:

17/5Αίθουσα MAKEDONIA HALL -
12:30-14:00 ROUND TABLE
Πρόεδροι: A. Peter,K. Kantartzis
12:30-13:00 Clusters of patients with Diabetes Mellitus type 2. Significance for prognosis and treatment
E. Schleicher
13:00-13:30 Pharmacogenetics of Type-2 Diabetes
H. Staiger
13:30-14:00 New insights in NAFLD and Diabetic Nephropathy in patients with Diabetes Mellitus type 2
G. Dimas


Watch the 2nd Joint International Scientific Meeting: "Meet the Expert" organised by  Hellenic Association for the Study & Education of Diabetes Mellitus along with the Department of Internal Medicine IV, University of Tübingen and the Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tübingen to held on 16 - 18 May 2019, at  Electra Palace, Thessaloniki
 
Sort by Date | Views
M. Bristianou | Management of Diabetes Mellitus... 570
K. Siomos | Cardiovascular safety of new... 472
Z. Kontoninas | Enteric Microbiome and Diabetes... 542
I. Migdalis | Prevention of Diabetes Mellitus... 495
M. Archaniotaki | CENTRAL LECTURE 466
C. Sampanis | OPENING CEREMONY 485
Charalampos Karvounis | OPENING CEREMONY 475
Walter Stechel | OPENING CEREMONY 421
Hans Ulrich Haring | OPENING CEREMONY 447
Theodoros Dardavesis | OPENING CEREMONY 480
K. Efstathiou | The Antikythira Mechanism... 531
I. Zografou | Management of Diabetes Mellitus... 526
E. Schleicher | Discrepancies between Blood... 498
G. Kourtoglou | Gestational Diabetes Mellitus 498
G. Kaiafa | Anemia and Diabetes Mellitus 464
E. Schleicher | Clusters of patients with... 504
H. Staiger | Pharmacogenetics of Type-2... 490
G. Dimas | New insights in NAFLD and Diabetic... 1.492
F. Artunc | Diabetic Nephropathy 507
S. Bakatselos | The clinical use of a fixed-dose... 513
C. Savopoulos | Diabetes Mellitus and Hypertension 483
T. Didangelos | Diabetic autonomic neuropathy 510
G. Arsos | Imaging investigation of the... 497
K. Kantartzis | SGLT2 in the treatment Diabetes... 452
S. Bakatselos | Hypoglycemia 516
C. Weigert | Running for a future without... 472
A. Mitrakou | Exercise and Diabetes Mellitus... 516
S. Tesfaye | New insights in the treatment... 499
C. Margaritidis | New data from the new... 534
N. Lalic | Insulin pump therapy in Type... 503
M. Archaniotaki | New emerging roles of... 499
Spyros Bakatselos 444
K. Kantartzis 459
S. Tesfaye 451
T. Didangelos | Diabetic Autonomic Neuropathy... 480
Ch. Savopoulos 474
N.Lalic 429
T. Didangelos 474
T. Karamitsos | The role of Cardiac MRI... 492
R. Lehmann | Blood samples for diabetes... 490
H. Priessl 457
H. - P. Hammers 400
E. Schleicher 439
D. Karamanos | Diabetic peripheral vascular... 509
A. Tesfaye | Management of diabetic foot... 491
T. Didangelos | WORKSHOP (25 Participants) 422
P. Giannoulaki | Nutritional training in... 500
T. Didangelos | Continuous glucose monitoring 475
A. Mitrakou | Time in range 475
J. GAVRIATOPOYLOS | WORKSHOP 467
16/05 MAKEDONIA HALL
16:30 - 17:00
Registration 

Evaluated
Evaluation
17:00 - 18:00
ROUND TABLE 

Obesity and Diabetes Mellitus

Evaluated
Evaluation
17:00 - 17:30
Management of Diabetes Mellitus type 2 and Obesity individually

Evaluated
Evaluation

Speaker: M. Bristianou(   )

17:30 - 18:00
Cardiovascular safety of new drugs for the treatment of obesity and diabetes

Evaluated
Evaluation

Speaker: K. Siomos(   )

Chairmen: Ch. Sampanis, D. Dimitriou

18:00 - 18:45
LECTURES 

Evaluated
Evaluation
18:00 - 18:20
Pancreatic fat accumulation, extracellular matrix expression and inflammation in healthy, pre-diabetic and diabetic individuals

Evaluated
Evaluation

Speaker: D. Siegel-Axel(   )

18:20 - 18:45
Enteric Microbiome and Diabetes Mellitus

Evaluated
Evaluation

Speaker: Z. Kontoninas

Chairmen: L. Lanaras, P. Evripidou

18:45 - 19:15
LECTURE 

Evaluated
Evaluation
18:45 - 19:15
Prevention of Diabetes Mellitus type 2

Evaluated
Evaluation

Speaker: I. Migdalis(   )

Chairmαn: D. Karamitsos

19:15 - 20:00
CENTRAL LECTURE 

Evaluated
Evaluation
19:15 - 20:00
Noncoding RNAs in glucose metabolism: role of their misexpression in type 2 diabetes

Evaluated
Evaluation

Speaker: E. Van Obberghen

Chairmαn: M. Archaniotaki

20:00 - 21:00
OPENING CEREMONY 

Evaluated
Evaluation
20:00 - 20:20
Welcome

Evaluated
Evaluation
20:20 - 21:00
The Antikythira Mechanism (An Ancient Greek Computer, a part of the Presentation will be in German Language)

Evaluated
Evaluation

Speaker: K. Efstathiou

Chairmαn: Ch. Sampanis

17/05 MAKEDONIA HALL
09:00 - 09:30
LECTURE 

Evaluated
Evaluation
09:00 - 09:30
Management of Diabetes Mellitus type 2 during hospitalization

Evaluated
Evaluation

Speaker: I. Zografou

Chairmαn: Ch. Sampanis

09:30 - 10:00
LECTURE 

Evaluated
Evaluation
09:30 - 10:00
Low calorie diet in Diabetes Mellitus type 2

Evaluated
Evaluation

Speaker: P. Giannoulaki

Chairmαn: D. Karagianni

10:00 - 11:00
ROUND TABLE 

Laboratory assessment and evaluation of Diabetes Mellitus and pre diabetes

Evaluated
Evaluation
10:00 - 10:30
Discrepancies between Blood Glucose and HbA1c in diabetic patients. How to proceed in individual cases

Evaluated
Evaluation

Speaker: E. Schleicher(   )

10:30 - 11:00
HbA1c for screening and diagnosis of Diabetes Mellitus - applications and future alternatives

Evaluated
Evaluation

Speaker: A. Peter

Chairmen: I. Migdalis, E. Schleicher

11:00 - 11:30
Coffee break 

11:30 - 12:00
LECTURE 

Evaluated
Evaluation
11:30 - 12:00
Gestational Diabetes Mellitus

Evaluated
Evaluation

Speaker: G. Kourtoglou(   )

Chairmαn: H. Staiger

12:00 - 12:30
LECTURE 

Evaluated
Evaluation
12:00 - 12:30
Anemia and Diabetes Mellitus

Evaluated
Evaluation

Speaker: G. Kaiafa(   )

Chairmαn: V. Perifanis

12:30 - 14:00
ROUND TABLE 

Evaluated
Evaluation
12:30 - 13:00
Clusters of patients with Diabetes Mellitus type 2. Significance for prognosis and treatment

Evaluated
Evaluation

Speaker: E. Schleicher(   )

13:00 - 13:30
Pharmacogenetics of Type-2 Diabetes

Evaluated
Evaluation

Speaker: H. Staiger(   )

13:30 - 14:00
New insights in NAFLD and Diabetic Nephropathy in patients with Diabetes Mellitus type 2

Evaluated
Evaluation

Speaker: G. Dimas(   )

Chairmen: A. Peter, K. Kantartzis

14:00 - 15:00
Break 

15:00 - 15:30
LECTURE 

Evaluated
Evaluation
15:00 - 15:30
Diabetic Nephropathy

Evaluated
Evaluation

Speaker: F. Artunc(   )

Chairmαn: A. Papagianni

15:30 - 16:00
LECTURE 

Evaluated
Evaluation
15:30 - 16:00
Diabetic Retinopathy

Evaluated
Evaluation

Speaker: H.-P. Hammes

Chairmαn: F. Topouzis

16:00 - 17:30
ROUND TABLE 

Treatment of Diabetes Mellitus type 2

Evaluated
Evaluation
16:00 - 16:30
Treatment of NAFLD in patients with Diabetes Mellitus Type 2

Evaluated
Evaluation

Speaker: N. Stefan

16:30 - 17:00
The clinical use of a fixed-dose Combination of Insulin and GLP-1 for the Treatment of Type 2 Diabetes

Evaluated
Evaluation

Speaker: S. Bakatselos

17:00 - 17:30
Brain derived modulation of human metabolism

Evaluated
Evaluation

Speaker: M. Heni

Chairmen: N. Stefan, S. Bakatselos

17:30 - 18:00
LECTURE 

Evaluated
Evaluation
17:30 - 18:00
Diabetes Mellitus and Hypertension

Evaluated
Evaluation

Speaker: Ch. Savopoulos(   )

Chairmαn: A. Hatzitolios

18:00 - 20:00
WORKSHOP (25 participants) 

Diabetic Neuropathy –Diabetic foot 1st session

Evaluated
Evaluation
18:00 - 18:40
Painful diabetic neuropathy

Evaluated
Evaluation

Speaker: S. Tesfaye(   )

18:40 - 19:20
Diabetic autonomic neuropathy

Evaluated
Evaluation

Speaker: T. Didangelos(   )

19:20 - 20:00
Imaging investigation of the diabetic foot

Evaluated
Evaluation

Speaker: G. Arsos(   )

Chairmen: S. Tesfaye, T. Didangelos

18/05 MAKEDONIA HALL
09:00 - 09:30
LECTURE 

Evaluated
Evaluation
09:00 - 09:30
SGLT2 in the treatment Diabetes Mellitus

Evaluated
Evaluation

Speaker: K. Kantartzis

Chairmαn: Sp. Bakatselos

09:30 - 11:00
ROUND TABLE 

Diabetes Mellitus and Exercise

Evaluated
Evaluation
09:30 - 10:00
Hypoglycemia

Evaluated
Evaluation

Speaker: S. Bakatselos

10:00 - 10:30
Running for a future without diabetes?

Evaluated
Evaluation

Speaker: C. Weigert(   )

10:30 - 11:00
Exercise and Diabetes Mellitus type 1

Evaluated
Evaluation

Speaker: A. Mitrakou(   )

Chairmen: S. Bakatselos, C. Weigert

11:00 - 11:30
Coffee break 

11:30 - 12:00
LECTURE 

Evaluated
Evaluation
11:30 - 12:00
New insights in the treatment of painful diabetic neuropathy

Evaluated
Evaluation

Speaker: S. Tesfaye(   )

Chairmαn: T. Didangelos

12:00 - 12:30
LECTURE 

Evaluated
Evaluation
12:00 - 12:30
Incretin based therapies: new cardiovascular data and development of novel molecules for the treatment of type 2 diabetes

Evaluated
Evaluation

Speaker: B. Gallwitz

Chairmαn: S. Bakatselos

12:30 - 13:00
LECTURE 

Evaluated
Evaluation
12:30 - 13:00
New data from the new basal insulin analogs titration in every day clinical practice

Evaluated
Evaluation

Speaker: C. Margaritidis(   )

Chairmαn: T. Didangelos

13:00 - 14:00
ROUND TABLE 

Insulin Pumps and New Technology in Diabetes

Evaluated
Evaluation
13:00 - 13:30
Insulin pump therapy in Type 2 Diabetes

Evaluated
Evaluation

Speaker: N. Lalic

13:30 - 14:00
The changing role of the clinician with the use of automated Insulin delivery systems

Evaluated
Evaluation

Speaker: O. Cohen

Chairmen: O. Cohen, A. Mitrakou

14:00 - 15:00
Break 

15:00 - 15:30
LECTURE 

Evaluated
Evaluation
15:00 - 15:30
New emerging roles of metformin

Evaluated
Evaluation

Speaker: M. Archaniotaki(   )

Chairmαn: F. Machicao

15:30 - 16:30
ROUND TABLE 

Diabetes Mellitus and Heart

Evaluated
Evaluation
15:30 - 16:00
Diabetic Autonomic Neuropathy and Cardiovascular Function

Evaluated
Evaluation

Speaker: T. Didangelos(   )

16:00 - 16:30
The role of Cardiac MRI in Diabetes

Evaluated
Evaluation

Speaker: Th. Karamitsos(   )

Chairmαn: K. Kantartzis

16:30 - 17:30
ROUND TABLE 

Insulin and the brain

Evaluated
Evaluation
16:30 - 17:00
Blood samples for diabetes research – anything to consider before starting OMICS investigations?

Evaluated
Evaluation

Speaker: R. Lehmann(   )

17:00 - 17:30
Modulation of the brain reward system by brain insulin action

Evaluated
Evaluation

Speaker: H. Preissl(   )

Chairmen: H.-U. Häring, G. Koliakos

17:30 - 18:00
LECTURE 

Evaluated
Evaluation
17:30 - 18:00
The role of brain insulin resistance for the development of prediabetic phenotypes

Evaluated
Evaluation

Speaker: H.-U. Häring(   )

Chairmαn: D. Karamitsos

18:00 - 20:00
WORKSHOP (25 Participants) 

Diabetic Neuropathy – Diabetic foot 2nd Session

Evaluated
Evaluation
18:00 - 18:20
Diabetic foot

Evaluated
Evaluation

Speaker: T. Didangelos

18:20 - 18:40
Diabetic peripheral vascular disease

Evaluated
Evaluation

Speaker: D. Karamanos(   )

18:40 - 19:00
Diabetic peripheral neuropathy

Evaluated
Evaluation

Speaker: C. Margaritidis

19:00 - 19:20
Diabetic cardiovascular autonomic neuropathy

Evaluated
Evaluation

Speaker: E. Karlafti

19:20 - 19:40
Management of diabetic foot ulcer

Evaluated
Evaluation

Speaker: A. Tesfaye(   )

19:40 - 20:00
Discussion

Chairmen: T. Gerasimidis, T. Didangelos

19/05 MAKEDONIA HALL
10:00 - 14:30
WORKSHOP (25 Participants) 

Insulin Pumps and New Technology in Diabetes

Evaluated
Evaluation
10:00 - 10:45
Nutritional training in insulin pump users

Evaluated
Evaluation

Speaker: P. Giannoulaki

10:45 - 11:30
Time in range

Evaluated
Evaluation

Speaker: A. Mitrakou(   )

11:30 - 12:15
Continuous glucose monitoring

Evaluated
Evaluation

Speaker: T. Didangelos(   )

12:15 - 12:45
Break

Evaluated
Evaluation
12:45 - 13:30
Optimizing glycemic control with MM670G hybrid closed loop system

Evaluated
Evaluation

Speaker: O. Cohen

13:30 - 14:30
Discussion

Chairmen: A. Mitrakou, T. Didangelos